Automated System
System Message
Replay available
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) Q2 2026 earnings conference call, held 2026-08-13. Replay captured from the company's public earnings webcast.

System Message
Analyst, Canaccord Genuity
Chief Executive Officer
Analyst, Craig-Hallam
Chief Financial Officer
Chief Commercial Officer
Chief Business Officer
Analyst, B-Raleigh Securities
Watch the replay and follow the connected company analysis, news, and investor updates for Eton Pharmaceuticals, Inc..
WEBVTT 00:00:01.047 -- 00:00:05.851 Good afternoon and welcome to the Eaton Pharmaceuticals second quarter 2026 financial 00:00:05.851 -- 00:00:10.615 results conference call. At this time, all participants are in listen-only mode. 00:00:10.615 -- 00:00:14.478 Following the formal remarks, we will open the call up for your questions. 00:00:14.478 -- 00:00:18.701 Please be advised this call is being recorded at the company's request. 00:00:18.701 -- 00:00:22.885 At this time, I'd like to turn the call over to David Krempa, Chief Business Officer 00:00:22.885 -- 00:00:26.946 at Eaton Pharmaceuticals. Please proceed. 00:00:27.348 -- 00:00:31.793 Thank you, Operator. Good afternoon, everyone, and welcome to Eaton's second quarter 00:00:31.793 -- 00:00:36.836 2026 conference call. This afternoon, we issued a press release that outlines 00:00:36.836 -- 00:00:39.817 the topics we plan to discuss on today's call. 00:00:39.817 -- 00:00:43.758 The release is available on our website, eatonpharma.com. 00:00:43.780 -- 00:00:48.142 Joining me on our call today, we have Sean Brynjelsen, our CEO, 00:00:48.142 -- 00:00:53.085 Ipek Trinkaus, our Chief Commercial Officer, and Judith Matthews, our Chief Financial 00:00:53.085 -- 00:00:54.505 Officer. 00:00:54.505 -- 00:00:59.248 Before we begin, I would like to remind everyone that today's remarks made during the 00:00:59.248 -- 00:01:04.351 call may contain forward-looking statements and involve risks and uncertainties that 00:01:04.351 -- 00:01:09.394 could cause actual results to differ materially from those contained in these forward-looking 00:01:09.394 -- 00:01:10.915 statements. 00:01:10.915 -- 00:01:15.097 Please see the forward-looking statements disclaimer in our earnings release and the 00:01:15.097 -- 00:01:19.340 risk fact...